Latest Insider Transactions at Pfizer Inc (PFE)
This section provides a real-time view of insider transactions for Pfizer Inc (PFE). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of PFIZER INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of PFIZER INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 30
2024
|
Scott Gottlieb Director |
BUY
Open market or private purchase
|
Direct |
1,000
+9.09%
|
$28,000
$28.24 P/Share
|
|
Aug 31
2024
|
Aamir Malik Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
20,195
-40.6%
|
$585,655
$29.01 P/Share
|
|
Aug 13
2024
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
5,154
-37.52%
|
$144,312
$28.66 P/Share
|
|
May 31
2024
|
David M Denton Chief Financial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
12,107
-24.2%
|
$338,996
$28.66 P/Share
|
|
Feb 28
2024
|
Christoffel Boshoff Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
4,150
-2.59%
|
$112,050
$27.04 P/Share
|
|
Feb 28
2024
|
Christoffel Boshoff Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
11,510
+6.7%
|
-
|
|
Feb 28
2024
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
21,437
-6.25%
|
$578,799
$27.04 P/Share
|
|
Feb 27
2024
|
Alexandre De Germay Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
74,377
+50.0%
|
-
|
|
Feb 27
2024
|
Jennifer B. Damico SVP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
5,113
+27.48%
|
-
|
|
Feb 26
2024
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,063
-7.44%
|
$163,701
$27.18 P/Share
|
|
Feb 25
2024
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,386
-14.19%
|
$37,422
$27.76 P/Share
|
|
Feb 25
2024
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,992
-3.54%
|
$80,784
$27.76 P/Share
|
|
Feb 25
2024
|
Christoffel Boshoff Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
6,197
-2.02%
|
$167,319
$27.76 P/Share
|
|
Feb 25
2024
|
Christoffel Boshoff Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
15,455
+9.08%
|
-
|
|
Feb 24
2024
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
354
-3.5%
|
$9,558
$27.76 P/Share
|
|
Feb 24
2024
|
Christoffel Boshoff Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
300
-0.21%
|
$8,100
$27.76 P/Share
|
|
Feb 23
2024
|
Albert Bourla Chairman & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
112,009
-12.98%
|
$3,024,243
$27.57 P/Share
|
|
Feb 23
2024
|
Albert Bourla Chairman & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
127,674
+22.5%
|
$3,447,198
$27.34 P/Share
|
|
Feb 23
2024
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
9,106
-16.75%
|
$245,862
$27.63 P/Share
|
|
Feb 23
2024
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
9,752
+33.65%
|
$263,304
$27.34 P/Share
|
|
Feb 23
2024
|
Mikael Dolsten President R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
24,822
-6.75%
|
$670,194
$27.76 P/Share
|
|
Feb 23
2024
|
Rady A Johnson Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
25,920
-10.7%
|
$699,840
$27.57 P/Share
|
|
Feb 23
2024
|
Rady A Johnson Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
29,436
+19.3%
|
$794,772
$27.34 P/Share
|
|
Feb 23
2024
|
Douglas M Lankler Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
84,002
-18.68%
|
$2,268,054
$27.57 P/Share
|
|
Feb 23
2024
|
Douglas M Lankler Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
95,755
+29.31%
|
$2,585,385
$27.34 P/Share
|
|
Feb 23
2024
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,219
-15.13%
|
$275,913
$27.57 P/Share
|
|
Feb 23
2024
|
Payal Sahni Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
11,527
+24.99%
|
$311,229
$27.34 P/Share
|
|
Feb 23
2024
|
Sally Susman Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
56,537
-13.23%
|
$1,526,499
$27.57 P/Share
|
|
Feb 23
2024
|
Sally Susman Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
63,837
+22.64%
|
$1,723,599
$27.34 P/Share
|
|
Feb 23
2024
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
10,890
-5.75%
|
$294,030
$27.57 P/Share
|
|
Feb 23
2024
|
Michael Mc Dermott Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
12,412
+11.51%
|
$335,124
$27.34 P/Share
|
|
Feb 23
2024
|
Christoffel Boshoff Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,014
-2.03%
|
$243,378
$27.63 P/Share
|
|
Feb 23
2024
|
Christoffel Boshoff Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
9,752
+6.15%
|
$263,304
$27.34 P/Share
|
|
Dec 29
2023
|
Christoffel Boshoff Executive Vice President |
BUY
Grant, award, or other acquisition
|
Direct |
34,734
+20.19%
|
-
|
|
Dec 15
2023
|
Scott Gottlieb Director |
BUY
Open market or private purchase
|
Direct |
3,000
+25.0%
|
$78,000
$26.47 P/Share
|
|
May 31
2023
|
David M Denton Chief Financial Officer & EVP |
SELL
Payment of exercise price or tax liability
|
Direct |
16,223
-25.17%
|
$616,474
$38.02 P/Share
|
|
May 08
2023
|
Scott Gottlieb Director |
BUY
Open market or private purchase
|
Direct |
1,000
+14.29%
|
$38,000
$38.58 P/Share
|
|
May 05
2023
|
Scott Gottlieb Director |
BUY
Open market or private purchase
|
Direct |
1,000
+16.67%
|
$38,000
$38.42 P/Share
|
|
Mar 31
2023
|
William Pao Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
22,095
-18.43%
|
$883,800
$40.8 P/Share
|
|
Mar 15
2023
|
Jennifer B. Damico SVP & Controller |
SELL
Open market or private sale
|
Direct |
9,912
-52.4%
|
$396,480
$40.02 P/Share
|
|
Feb 27
2023
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
1,297
-5.32%
|
$51,880
$40.78 P/Share
|
|
Feb 27
2023
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
1,427
-6.89%
|
$57,080
$40.78 P/Share
|
|
Feb 27
2023
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
3,081
-3.67%
|
$123,240
$40.78 P/Share
|
|
Feb 25
2023
|
Payal Sahni Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
5,753
-9.96%
|
$241,626
$42.59 P/Share
|
|
Feb 25
2023
|
Payal Sahni Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
8,921
+22.85%
|
$196,262
$22.89 P/Share
|
|
Feb 25
2023
|
Jennifer B. Damico SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
7,191
-13.66%
|
$302,022
$42.59 P/Share
|
|
Feb 25
2023
|
Jennifer B. Damico SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
11,150
+28.56%
|
$245,300
$22.89 P/Share
|
|
Feb 25
2023
|
Angela Hwang President, Global Biopharma |
SELL
Payment of exercise price or tax liability
|
Direct |
14,763
-18.07%
|
$620,046
$42.59 P/Share
|
|
Feb 25
2023
|
Angela Hwang President, Global Biopharma |
BUY
Exercise of conversion of derivative security
|
Direct |
20,273
+31.28%
|
$446,006
$22.89 P/Share
|
|
Feb 25
2023
|
Michael Mc Dermott Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
9,144
-5.02%
|
$384,048
$42.59 P/Share
|